©The Author(s) 2025.
World J Hepatol. Dec 27, 2025; 17(12): 113639
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.113639
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.113639
Table 2 Share of steatotic liver disease among patients with risk factors, n (%)
| Parameter | Arterial hypertension | Diabetes | Hyperlipidemia | Overweight + obesity | Alcohol | GT3 |
| All/688 | 239 (34.7) | 73 (10.6) | 89 (12.9) | 290 (42.2) | 82 (11.9) | 114 (16.6) |
| SLD | 108 (45.2) | 41 (56.2) | 50 (56.2) | 181 (56.2) | 67 (81.7) | 71 (62.3) |
| Non-SLD | 131 (54.8) | 32 (43.8) | 39 (43.8) | 109 (43.8) | 15 (18.3) | 43 (37.7) |
| P value | 0.0354 | 0.1363 | 0.0991 | < 0.0001 | < 0.0001 | 0.0002 |
- Citation: Janczura J, Brzdęk M, Flisiak R, Dobrowolska K, Brzdęk K, Rzymski P, Zarębska-Michaluk D. Steatotic liver disease in patients with chronic hepatitis C. World J Hepatol 2025; 17(12): 113639
- URL: https://www.wjgnet.com/1948-5182/full/v17/i12/113639.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i12.113639